Zika virus could be a promising treatment for glioblastoma, which is the most common form of brain cancer, finds a new study.
Highlights:
- The Zika virus, which has caused birth defects could be used to treat glioblastoma, which is the most common and aggressive forms of brain tumor
- The virus can destroy glioblastoma cancer cells in the same way it attacks the developing brains of fetuses
- The findings could lead to the development of new, effective treatments for this type of brain tumor
Can Zika Virus Kill Hard-to-Treat Glioblastoma Cells?
Currently available treatments for glioblastoma are limited by their ability to cross the blood-brain barrier. The doses of the drugs have been kept low to avoid damage to healthy brain tissues. But, the Zika virus can cross the blood-brain barrier and could target cancer cells, opening a potential new way to treat glioblastoma.
Zika virus infection during pregnancy causes birth defects in babies by attacking the stem cells in the developing brain. But in adults, Zika virus causes only mild-flu like symptoms because the adult brain is fully developed. In brain tumor, the cancer cells resemble those in the developing brain, suggesting that the Zika virus could attack them too.
How Zika Virus Destroys Glioblastoma Cells
"We hypothesized that the preference of Zika virus for neural precursor cells could be leveraged against glioblastoma stem cells," says Michael Diamond, also from Washington University School of Medicine in St. Louis, who co-directed the study with Milan Chheda and with Jeremy Rich, from the University of California, San Diego and the Cleveland Clinic Lerner Research Institute.
The research team conducted a study on mice with aggressive glioma to see how Zika virus kills brain cancer stem cells. Mice with aggressive glioma were injected with a mouse-adapted strain of Zika virus. The team found that Zika virus slowed tumor growth and significantly extended the lifespan of mice. Zika virus infected patient-derived glioblastoma stem cells compared with other glioblastoma cell types or normal neural cells.
The team also tested a mutant strain of Zika virus, which is less virulent than naturally occurring strains of the virus. They found that the attenuated strain, which is more sensitive to the body’s immune response was still able to specifically target and kill glioblastoma stem cells. The attenuated strain was even more effective when combined with a chemotherapy drug called temozolomide, which usually has little effect on glioblastoma cells.
The study represents the creative synthesis of three research groups with complementary expertise to attack brain cancer cells by harnessing the cause of another disease. “Adults with Zika virus may suffer less damage from their infection so that this approach could be used with acceptable toxicity.” said Jeremy Rich.
This study is the first step towards the development of safe and effective strains of Zika virus that is important in neuro-oncology and in the treatment of glioblastoma. However, public health concerns should be addressed through pre-clinical testing and evaluations of the strains’ ability to disseminate or revert to more virulent forms.
Reference:
- Scientists to test Zika virus on brain tumours - (https://www.curebraincancer.org.au/news/1428/scientists-to-test-zika-virus-on-brain-tumours)